Edition:
United States

Profile: H Lundbeck A/S (LUN.CO)

LUN.CO on Copenhagen Stock Exchange

251.10DKK
6:24am EDT
Change (% chg)

kr.-1.00 (-0.40%)
Prev Close
kr.252.10
Open
kr.250.30
Day's High
kr.251.40
Day's Low
kr.248.00
Volume
93,215
Avg. Vol
315,385
52-wk High
kr.476.40
52-wk Low
kr.248.00

H Lundbeck A/S is a Denmark-based company active in the pharmaceuticals industry. It is engaged in the research, development, manufacture and marketing of pharmaceuticals for the treatment of brain disorders, such as Alzheimer’s disease, Bipolar disorder, depression, epilepsy, Huntington’s disease, Parkinson’s disease and schizophrenia. Its product portfolio includes: Cipralex for the treatment of depression and anxiety disorders, Ebixa for the treatment of Alzheimer’s disease, Azilect for the treatment of Parkinson’s disease, Xenazine for the treatment of Huntington’s disease and Sabril for the treatment of epilepsy, among others. The Company operates through a number of subsidiaries, such as Lundbeck SAS, Lundbeck GmbH, SIA Lundbeck Latvia and Lundbeck LLC.

Company Address

H Lundbeck A/S

Ottiliavej 9
VALBY     2500

Company Web Links